Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PMGC Holdings Inc. - Common Stock (NQ:ELAB)

7.440 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PMGC Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning! 
Via InvestorPlace
ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
Utility Patent Covers the formulation for ELEVAI’s flagship exosome-based skin care products 
From Elevai Labs Inc.
Via GlobeNewswire
Top 4 Defensive Stocks That Could Lead To Your Biggest Gains In January
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
ELAB Stock Earnings: Elevai Labs Reported Results for Q3 2024
Elevai Labs just reported results for the third quarter of 2024. 
Via InvestorPlace
ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
From Elevai Labs Inc.
Via GlobeNewswire
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market... 
Via Benzinga
Why Is Elevai Labs (ELAB) Stock Up Today?
Elevai Labs is soaring on an intriguing licensing agreement with INmune Bio, but the narrative presents a mixed bag for ELAB stock. 
Via InvestorPlace
Why Elevai Labs Stock Is Trading Higher
Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune... 
Via Benzinga
Dow Dips 200 Points; Goldman Sachs Earnings Top Views
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ... 
Via Benzinga
Topics Stocks
ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology
ELEVAI Labs to commercialize use of proprietary technology designed to produce high-quality, cGMP grade mesenchymal stromal cells at lower-cost 
From Elevai Labs Inc.
Via GlobeNewswire
ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to... 
Via Benzinga
Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023
Company Records Record Quarterly Revenues 
From Elevai Labs Inc.
Via GlobeNewswire
ELEVAI Labs, Inc. Expands International Distribution into Europe
From Elevai Labs Inc.
Via GlobeNewswire
Fenbo Holdings Debuts In Another Slow Week For IPOs
Fenbo Holdings made its trading debut on Thursday in another slow IPO week in the US. Entering the last month of 2023, the outlook for 2024 market debuts looks better, as it would be difficult to be... 
Via Talk Markets
Topics Initial Public Offering
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results. 
Via Benzinga
Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products
From Elevai Labs Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.